×
About 58,434 results

ALLMedicine™ Hepatitis C Virus Center

Research & Reviews  28,057 results

N6-methyladenosine modification of HCV RNA genome regulates cap-independent IRES-mediat...
https://doi.org/10.1073/pnas.2022024118
Proceedings of the National Academy of Sciences of the Un... Kim GW, Siddiqui A

Mar 2nd, 2021 - Hepatitis C virus (HCV) infections are associated with the risk of progression to fibrosis, cirrhosis, and hepatocellular carcinoma. The HCV RNA genome is translated by an internal ribosome entry site (IRES)-dependent mechanism. The structure and ...

Comorbidities in patients with chronic hepatitis C and hepatitis B on hemodialysis.
https://doi.org/10.1111/jgh.15480
Journal of Gastroenterology and Hepatology; Hsu PY, Wei YJ et. al.

Mar 2nd, 2021 - Hemodialysis patients are at increased risk of hepatitis B virus (HBV) and hepatitis C virus (HCV) infection. Both HBV and HCV infections lead to risks of end-stage liver diseases and extrahepatic manifestations. This study aimed to investigate he...

REDUCTION IN THE POPULATION PREVALENCE OF HCV VIRAEMIA AMONG PEOPLE WHO INJECT DRUGS AS...
https://doi.org/10.1111/add.15459
Addiction (Abingdon, England); Palmateer NE, McAuley A et. al.

Mar 2nd, 2021 - There has been little empirical evidence to show the 'real world' impact of scaling-up direct-acting antiviral (DAA) treatment among people who inject drugs (PWID) on hepatitis C virus (HCV) viraemia at a population level. We aimed to assess the p...

Outbreak of hepatitis B and hepatitis C virus infections associated with a cardiology c...
https://doi.org/10.1017/ice.2021.31
Infection Control and Hospital Epidemiology; Tressler SR, Del Rosario MC et. al.

Mar 1st, 2021 - To stop transmission of hepatitis B virus (HBV) and hepatitis C virus (HCV) infections in association with myocardial perfusion imaging (MPI) at a cardiology clinic. Outbreak investigation and quasispecies analysis of HCV hypervariable region 1 ge...

Modelling the intervention effect of opioid agonist treatment on multiple mortality out...
https://doi.org/10.1016/S2215-0366(20)30538-1
The Lancet. Psychiatry; Stone J, Degenhardt L et. al.

Feb 28th, 2021 - Opioid agonist treatment (OAT) reduces many of the harms associated with opioid dependence. We use mathematical modelling to comprehensively evaluate the overall health benefits of OAT in people who inject drugs in Perry County (KY, USA), Kyiv (Uk...

see more →

Guidelines  51 results

Fibrosis regression after eradication of hepatitis C virus - from bench to bedside.
https://doi.org/10.1053/j.gastro.2020.09.065
Gastroenterology Rockey DC, Friedman SL

Feb 2nd, 2021 - Hepatitis C virus (HCV) infection and its complications have been the major cause of cirrhosis and its complications for several decades in the Western world. Until recently, treatment for HCV with interferon-based regimens was associated with mod...

EASL recommendations on treatment of hepatitis C: Final update of the series☆.
https://doi.org/10.1016/j.jhep.2020.08.018
Journal of Hepatology; , et. al.

Sep 21st, 2020 - Hepatitis C virus (HCV) infection is a major cause of chronic liver disease, with approximately 71 million chronically infected individuals worldwide. Clinical care for patients with HCV-related liver disease has advanced considerably thanks to an...

Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C Virus Infection in Chronic Kidney Disease: Synopsis of the Kidney Disease: Improving Global Outcomes 2018 Clinical Practice Guideline
https://annals.org/aim/fullarticle/2751913/prevention-diagnosis-evaluation-treatment-hepatitis-c-virus-infection-chronic-kidney

Sep 23rd, 2019 - Description: The Kidney Disease: Improving Global Outcomes (KDIGO) 2018 clinical practice guideline for the prevention, diagnosis, evaluation, and treatment of hepatitis C virus (HCV) infection in chronic kidney disease (CKD) is an extensive updat...

Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C Virus Infection in Chro...
https://doi.org/10.7326/M19-1539
Annals of Internal Medicine; Gordon CE, Berenguer MC et. al.

Sep 23rd, 2019 - This article has been corrected. The original version (PDF) is appended to this article as a Supplement. The Kidney Disease: Improving Global Outcomes (KDIGO) 2018 clinical practice guideline for the prevention, diagnosis, evaluation, and treatmen...

FDA warns about rare occurrence of serious liver injury with use of hepatitis C medicines Mavyret, Zepatier, and Vosevi in some patients with advanced liver disease
https://www.fda.gov/drugs/drug-safety-and-availability/fda-warns-about-rare-occurrence-serious-liver-injury-use-hepatitis-c-medicines-mavyret-zepatier-and

Aug 27th, 2019 - The Food and Drug Administration (FDA) has received reports that the use of Mavyret, Zepatier, or Vosevi to treat chronic hepatitis C in patients with moderate to severe liver impairment has resulted in rare cases of worsening liver function or li...

see more →

Drugs  33 results see all →

Clinicaltrials.gov  29,005 results

N6-methyladenosine modification of HCV RNA genome regulates cap-independent IRES-mediat...
https://doi.org/10.1073/pnas.2022024118
Proceedings of the National Academy of Sciences of the Un... Kim GW, Siddiqui A

Mar 2nd, 2021 - Hepatitis C virus (HCV) infections are associated with the risk of progression to fibrosis, cirrhosis, and hepatocellular carcinoma. The HCV RNA genome is translated by an internal ribosome entry site (IRES)-dependent mechanism. The structure and ...

Comorbidities in patients with chronic hepatitis C and hepatitis B on hemodialysis.
https://doi.org/10.1111/jgh.15480
Journal of Gastroenterology and Hepatology; Hsu PY, Wei YJ et. al.

Mar 2nd, 2021 - Hemodialysis patients are at increased risk of hepatitis B virus (HBV) and hepatitis C virus (HCV) infection. Both HBV and HCV infections lead to risks of end-stage liver diseases and extrahepatic manifestations. This study aimed to investigate he...

REDUCTION IN THE POPULATION PREVALENCE OF HCV VIRAEMIA AMONG PEOPLE WHO INJECT DRUGS AS...
https://doi.org/10.1111/add.15459
Addiction (Abingdon, England); Palmateer NE, McAuley A et. al.

Mar 2nd, 2021 - There has been little empirical evidence to show the 'real world' impact of scaling-up direct-acting antiviral (DAA) treatment among people who inject drugs (PWID) on hepatitis C virus (HCV) viraemia at a population level. We aimed to assess the p...

Outbreak of hepatitis B and hepatitis C virus infections associated with a cardiology c...
https://doi.org/10.1017/ice.2021.31
Infection Control and Hospital Epidemiology; Tressler SR, Del Rosario MC et. al.

Mar 1st, 2021 - To stop transmission of hepatitis B virus (HBV) and hepatitis C virus (HCV) infections in association with myocardial perfusion imaging (MPI) at a cardiology clinic. Outbreak investigation and quasispecies analysis of HCV hypervariable region 1 ge...

Modelling the intervention effect of opioid agonist treatment on multiple mortality out...
https://doi.org/10.1016/S2215-0366(20)30538-1
The Lancet. Psychiatry; Stone J, Degenhardt L et. al.

Feb 28th, 2021 - Opioid agonist treatment (OAT) reduces many of the harms associated with opioid dependence. We use mathematical modelling to comprehensively evaluate the overall health benefits of OAT in people who inject drugs in Perry County (KY, USA), Kyiv (Uk...

see more →

News  1,285 results

HCV Declines Level Off in HIV+ Men Who Have Sex With Men
https://www.medscape.com/viewarticle/943804

Jan 10th, 2021 - NEW YORK (Reuters Health) - The incidence of hepatitis C virus (HCV) infection among HIV-positive men who have sex with men in the Netherlands fell once direct-acting antivirals (DAAs) became universally available in 2015, new findings show. While...

One-Year Transplant Outcomes Similar With Kidneys From HCV+, HCV- Donors
https://www.medscape.com/viewarticle/942667

Dec 15th, 2020 - NEW YORK (Reuters Health) - Outcomes for renal transplants from hepatitis C virus (HCV)-infected donors to HCV-negative recipients are similar to those for HCV-negative patients who receive kidneys from donors without HCV, according to a one-year ...

Patients Cured of HCV Still at High Liver Cancer Risk
https://www.medscape.com/viewarticle/941615

Nov 25th, 2020 - NEW YORK (Reuters Health) - The burden of hepatocellular carcinoma (HCC) appears likely to move from patients who currently have hepatitis C virus (HCV) infection to those who have previously been cured, a new modeling study suggests. "The new hep...

Combo DAA Treatments May Benefit Patients With Resistant HCV Genotype 3
https://www.medscape.com/viewarticle/941464

Nov 22nd, 2020 - Patients with hepatitis C virus (HCV) genotype 3 infection have shown resistance to direct-acting antiviral (DAA) treatments. However, a meta-analysis of 34 research reports found that DAA combo treatment can be effective in achieving sustained vi...

Opt-Out Policy at a Syringe Service Program Increased HIV/HCV Testing
https://www.staging.medscape.com/viewarticle/941269

Nov 18th, 2020 - Bundled opt-out HIV/hepatitis C virus (HCV) testing increased the percentage of syringe service program (SSP) clients who received HIV and HCV rapid tests at enrollment into the program. Researchers conducted a retrospective comparative analysis o...

see more →

Patient Education  3 results see all →